|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Home > Press > Harris & Harris Group reports net asset value
The Company announced that in connection with a proposed public
offering of shares of common stock pursuant to an effective shelf
registration statement filed with the Securities and Exchange
Commission, as of today we have determined that our net asset value
per share is $5.07. The increase of $7,952,716 in our net asset
value since our most recently reported balance sheet data as of June
30, 2005, reflects an increase of $10,715,910 in the value of our
shares in NeuroMetrix, Inc. (Nasdaq: NURO), minus an increase of
$2,160,792 in our reserve for employee profit-sharing. For the
purpose of the accrual, we calculate 20 percent of qualifying income
pursuant to the terms of the profit-sharing plan and estimate the
effect on qualifying income of selling all the portfolio investments
that are valued above cost (i.e., are in an unrealized appreciation
position). This methodology results in a fluctuation in our accrual
but is not reflective of actual payments made under the profit-
sharing plan. Profit-sharing plan payments require the existence of
qualifying income and consider only realized gains and losses
(unrealized gains are excluded.
####
This press release may contain statements of a forward-looking
nature relating to future events. These forward-looking statements
are subject to the inherent uncertainties in predicting future
results and conditions. These statements reflect the Company's
current beliefs, and a number of important factors could cause
actual results to differ materially from those expressed in this
press release. Please see the Company's Registration Statement on
Form N-2 (File No. 333-112862) and Annual Report on Form 10-K for
the fiscal year ended December 31, 2004, each filed with the
Securities and Exchange Commission, for a more detailed discussion
of the risks and uncertainties associated with the Company's
business, including but not limited to the risks and uncertainties
associated with venture capital investing and other significant
factors that could affect the Company's actual results. Except as
otherwise required by Federal securities laws, Harris & Harris
Group, Inc.®, undertakes no obligation to update or revise these
forward-looking statements to reflect new events or uncertainties.
The reference to the website www.TinyTechVC.com
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Related News Press |
Investments/IPO's/Splits
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
Announcements
How do cold ions slide May 24th, 2013
Gold nanocrystal vibration captured on billion-frames-per-second film May 23rd, 2013
Financial Reports
Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013
Harris & Harris Group Reports Financial Statements as of March 31, 2013 May 10th, 2013
Arrowhead Reports Fiscal 2013 Second Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time May 9th, 2013
Arrowhead to Report Fiscal 2013 Second Quarter Financial Results - Conference Call Scheduled for Thursday, May 9, 2013 May 2nd, 2013
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
University Technology Transfer & Patents
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||
| © Copyright 1999-2013 7th Wave, Inc. All Rights Reserved | PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE |